0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover662.29%IV-1134.57%PremiumJul 19, 2024Expiry Date4.59Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9441Delta0.2986Gamma0.09Leverage Ratio-0.0018Theta-0.0006Rho-0.08Eff Leverage0.0001Vega
IGC Pharma Stock Discussion
Benzinga· 3 mins ago
Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that while Anson Funds disclosed its short position strategy to investors, it did not reveal its collaboratio...
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
Larger Image: tradingview.com...
$IGC Pharma(IGC.US)$
Get in on this
$IGC Pharma(IGC.US)$
No comment yet